Status not kept up to date
Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke
NCT04285060 · Samsung Electronics · Updated 27 Sept 2021
- What is being tested
- Samsung GEMS-H
- For
- Stroke; Chronic Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 100 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 12 Feb 2020, ends Dec 2021. Registered 26 Feb 2020.
- Results
- None posted yet.
In the researchers' words
A single-site, interventional, single-arm trial to evaluate the safety and efficacy on functional mobility following Samsung GEMS-H (Gait Enhancing and Motivating System - Hip) device training in participants with sub-acute and chronic stroke.
Sites
- Shirley Ryan AbilityLabChicago, Illinois, United States